Clinical studies recruiting near Oceanside

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Profound Research LLC ( Site 0105) · Merck Sharp & Dohme LLC · NCT06393374 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Excell Research · Kallyope Inc. · NCT07674654 Validating CGM for GDM
NA · Mount Sinai South Nassau · Icahn School of Medicine at Mount Sinai · NCT06858787 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Sharp Memorial Hospital · argenx · NCT06544499 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Profound Research LLC · Eli Lilly and Company · NCT06890598 Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living
Phase 3 · Kailera Clinical Site · Kailera · NCT07284979 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Mount Sinai South Nassau · NRG Oncology · NCT05174169 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06480383 Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06701903 Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT07484217 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Mount Sinai South Nassau · NRG Oncology · NCT06748222 A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Phase 3 · Excell Research Inc. · Xenon Pharmaceuticals Inc. · NCT06775379 Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipol
Phase 2 · Excell Research /ID# 273483 · AbbVie · NCT07220460 ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Phase 2 · Site 7082 · Alto Neuroscience · NCT07553637 Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Maj
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06966401 Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Phase 2 · Ophthalmic Consultants of Long Island · ONL Therapeutics · NCT06659445 A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Phase 4 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT06223880 Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Phase 3 · Profound Research, Dermatology Medical Group - Oceanside · Regeneron Pharmaceuticals · NCT06585410 Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07227818 Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatri
Phase 3 · Excell Research Inc · Intra-Cellular Therapies, Inc. · NCT06690398 NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07114874 A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressi
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07196501 MOTION Clinical Trial
NA · Scripps Clinic Jefferson · Moximed · NCT06843980 "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Phase 3 · Excell Research, Inc · Cybin IRL Limited · NCT06564818 A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Stu
Phase 2 · Atd002 52021 · UCB Biopharma SRL · NCT07277660 A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I
Phase 2 · Excell Research /ID# 272854 · AbbVie · NCT06696755 ALTO-100 in Bipolar Disorder With Depression (BD-D)
Phase 2 · Site 6082 · Alto Neuroscience · NCT06656416 A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupil
Phase 3 · Dermatologist Medical Group of North County- Profound Resear · AbbVie · NCT06389136 A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participant
Phase 3 · Ophthalmic Consultants of Long Island - Research · Amgen · NCT07614776 A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic De
Phase 2 · Profound Research LLC · Pfizer · NCT05995964

Look up another city

Look up another condition